Symbol:
Ankrd1
Name:
ankyrin repeat domain 1
RGD ID:
61989
Description:
Predicted to enable several functions, including R-SMAD binding activity; cytoskeletal protein binding activity; and transcription coregulator activity. Involved in cellular response to hypoxia; negative regulation of transcription by RNA polymerase II; and positive regulation of neuron projection development. Located in I band and nucleus. Human ortholog(s) of this gene implicated in congenital structural myopathy; dilated cardiomyopathy; hypertrophic cardiomyopathy; nemaline myopathy; and spinal muscular atrophy. Orthologous to human ANKRD1 (ankyrin repeat domain 1); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Alrp; ankyrin repeat domain 1 (cardiac muscle); ankyrin repeat domain-containing protein 1; ankyrin-like repeat protein; cardiac adriamycin-responsive protein; cardiac ankyrin repeat protein; cardiac responsive adriamycin protein; Carp; Crap; LOC102552909; MARP; muscle ankyrin repeat protein; uncharacterized LOC102552909
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ANKRD1 (ankyrin repeat domain 1) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Ankrd1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ankrd1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ANKRD1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ANKRD1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ankrd1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ANKRD1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
ANKRD1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ankrd1 (ankyrin repeat domain 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
JMJD8 (jumonji domain containing 8) HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Ankrd1 (ankyrin repeat domain 1)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
ANKRD1 (ankyrin repeat domain 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ankrd1a (ankyrin repeat domain 1a (cardiac muscle))
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ankrd1b (ankyrin repeat domain 1b (cardiac muscle))
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
ankrd1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 243,228,460 - 243,237,014 (-) NCBI GRCr8 mRatBN7.2 1 233,815,851 - 233,834,891 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 233,815,851 - 233,834,919 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 242,212,709 - 242,221,290 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 249,129,677 - 249,138,264 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 241,967,834 - 241,976,421 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 254,726,985 - 254,745,673 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 254,726,969 - 254,735,548 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 262,038,137 - 262,046,691 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 240,316,123 - 240,324,804 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 240,490,005 - 240,498,684 (-) NCBI Celera 1 230,914,960 - 230,923,398 (-) NCBI Celera Cytogenetic Map 1 q53 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ankrd1 Rat 1,1-dichloroethene increases expression ISO Ankrd1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of ANKRD1 mRNA CTD PMID:26682919 Ankrd1 Rat 17beta-estradiol decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Estradiol results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 Ankrd1 Rat 17beta-estradiol increases expression ISO Ankrd1 (Mus musculus) 6480464 Estradiol results in increased expression of ANKRD1 mRNA CTD PMID:39298647 Ankrd1 Rat 17beta-estradiol multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ANKRD1 mRNA CTD PMID:30165855 Ankrd1 Rat 17beta-estradiol affects expression ISO ANKRD1 (Homo sapiens) 6480464 Estradiol affects the expression of ANKRD1 mRNA CTD PMID:21632981 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 and PMID:29704546 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANKRD1 mRNA CTD PMID:33387578 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin affects the methylation of ANKRD1 intron] which results in increased expression of ANKRD1 mRNA CTD PMID:33017471 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA] and [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of ANKRD1 mRNA CTD PMID:29704546 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ankrd1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ANKRD1 mRNA CTD PMID:21570461 Ankrd1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ankrd1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 Ankrd1 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Ankrd1 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Ankrd1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ANKRD1 mRNA CTD PMID:20188158 Ankrd1 Rat 4,4'-sulfonyldiphenol increases expression ISO ANKRD1 (Homo sapiens) 6480464 bisphenol S results in increased expression of ANKRD1 mRNA CTD PMID:25912373 Ankrd1 Rat 4,4'-sulfonyldiphenol increases expression ISO Ankrd1 (Mus musculus) 6480464 bisphenol S results in increased expression of ANKRD1 mRNA CTD PMID:30951980 Ankrd1 Rat 5-fluorouracil increases expression ISO ANKRD1 (Homo sapiens) 6480464 Fluorouracil results in increased expression of ANKRD1 mRNA CTD PMID:17039268 Ankrd1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ANKRD1 mRNA CTD PMID:24780913 and PMID:25825206 Ankrd1 Rat aflatoxin B1 affects expression ISO ANKRD1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of ANKRD1 protein CTD PMID:20106945 Ankrd1 Rat aflatoxin B1 increases methylation ISO ANKRD1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ANKRD1 gene CTD PMID:27153756 Ankrd1 Rat aflatoxin B1 increases expression ISO ANKRD1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ANKRD1 mRNA CTD PMID:22100608 and PMID:27153756 Ankrd1 Rat aflatoxin B1 decreases expression ISO Ankrd1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 Ankrd1 Rat amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of ANKRD1 mRNA CTD PMID:22341215 Ankrd1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANKRD1 mRNA CTD PMID:16483693 Ankrd1 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANKRD1 mRNA CTD PMID:30779732 Ankrd1 Rat ampicillin increases expression ISO ANKRD1 (Homo sapiens) 6480464 Ampicillin results in increased expression of ANKRD1 mRNA CTD PMID:21632981 Ankrd1 Rat andrographolide multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA CTD PMID:19737545 Ankrd1 Rat arsane increases expression ISO Ankrd1 (Mus musculus) 6480464 Arsenic results in increased expression of ANKRD1 mRNA CTD PMID:23942117 Ankrd1 Rat arsane multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat arsenic atom increases expression ISO Ankrd1 (Mus musculus) 6480464 Arsenic results in increased expression of ANKRD1 mRNA CTD PMID:23942117 Ankrd1 Rat arsenic atom multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ANKRD1 mRNA CTD PMID:36841081 Ankrd1 Rat benzo[a]pyrene increases expression ISO ANKRD1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ANKRD1 mRNA CTD PMID:21871943 more ... Ankrd1 Rat benzo[a]pyrene increases expression ISO Ankrd1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ANKRD1 mRNA CTD PMID:22610609 Ankrd1 Rat benzo[a]pyrene decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 more ... Ankrd1 Rat benzo[a]pyrene decreases expression ISO Ankrd1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 and PMID:22228805 Ankrd1 Rat beta-naphthoflavone multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA CTD PMID:19737545 Ankrd1 Rat bis(2-chloroethyl) sulfide increases expression ISO ANKRD1 (Homo sapiens) 6480464 Mustard Gas results in increased expression of ANKRD1 mRNA CTD PMID:25102026 Ankrd1 Rat bis(2-ethylhexyl) phthalate increases expression ISO ANKRD1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of ANKRD1 mRNA CTD PMID:31163220 Ankrd1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANKRD1 mRNA CTD PMID:25181051 Ankrd1 Rat bisphenol A decreases expression ISO ANKRD1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ANKRD1 mRNA CTD PMID:29275510 and PMID:29718440 Ankrd1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANKRD1 mRNA CTD PMID:30816183 Ankrd1 Rat bisphenol A increases expression ISO Ankrd1 (Mus musculus) 6480464 bisphenol A results in increased expression of ANKRD1 mRNA CTD PMID:30951980 and PMID:34585602 Ankrd1 Rat bisphenol F increases expression ISO Ankrd1 (Mus musculus) 6480464 bisphenol F results in increased expression of ANKRD1 mRNA CTD PMID:30951980 Ankrd1 Rat bleomycin A2 increases expression ISO Ankrd1 (Mus musculus) 6480464 Bleomycin results in increased expression of ANKRD1 mRNA CTD PMID:26345256 Ankrd1 Rat Botulinum toxin type A increases expression EXP 6480464 Botulinum Toxins and Type A results in increased expression of ANKRD1 mRNA CTD PMID:18603602 Ankrd1 Rat bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ANKRD1 mRNA CTD PMID:32479839 Ankrd1 Rat butanal increases expression ISO ANKRD1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of ANKRD1 mRNA CTD PMID:26079696 Ankrd1 Rat cadmium atom increases expression ISO ANKRD1 (Homo sapiens) 6480464 Cadmium results in increased expression of ANKRD1 mRNA CTD PMID:21172416 and PMID:33559965 Ankrd1 Rat cadmium dichloride decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of ANKRD1 mRNA CTD PMID:26314618 Ankrd1 Rat cadmium dichloride increases expression ISO ANKRD1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of ANKRD1 mRNA CTD PMID:38568856 Ankrd1 Rat cadmium sulfate increases expression ISO ANKRD1 (Homo sapiens) 6480464 cadmium sulfate results in increased expression of ANKRD1 mRNA CTD PMID:12064557 more ... Ankrd1 Rat calcipotriol multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [calcipotriene co-treated with Verteporfin] promotes the reaction [Carbon Tetrachloride results in increased expression of ANKRD1 mRNA] and calcipotriene promotes the reaction [Carbon Tetrachloride results in increased expression of ANKRD1 mRNA] CTD PMID:38992766 Ankrd1 Rat cantharidin decreases expression ISO Ankrd1 (Mus musculus) 6480464 Cantharidin results in decreased expression of ANKRD1 mRNA CTD PMID:36907384 Ankrd1 Rat carbon nanotube increases expression ISO Ankrd1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Ankrd1 Rat carmustine affects response to substance ISO ANKRD1 (Homo sapiens) 6480464 ANKRD1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 Ankrd1 Rat CGP 52608 multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ANKRD1 gene] CTD PMID:28238834 Ankrd1 Rat chlordecone decreases expression ISO Ankrd1 (Mus musculus) 6480464 Chlordecone results in decreased expression of ANKRD1 mRNA CTD PMID:33711761 Ankrd1 Rat choline multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 Ankrd1 Rat cisplatin increases expression ISO Ankrd1 (Mus musculus) 6480464 Cisplatin results in increased expression of ANKRD1 mRNA CTD PMID:21151649 Ankrd1 Rat cisplatin decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ANKRD1 mRNA CTD PMID:27392435 Ankrd1 Rat cisplatin multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ANKRD1 mRNA CTD PMID:27392435 Ankrd1 Rat cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ANKRD1 mRNA CTD PMID:22023808 Ankrd1 Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ANKRD1 mRNA CTD PMID:24386269 Ankrd1 Rat cobalt dichloride decreases expression ISO ANKRD1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ANKRD1 mRNA CTD PMID:19320972 Ankrd1 Rat copper(II) chloride increases expression ISO ANKRD1 (Homo sapiens) 6480464 cupric chloride results in increased expression of ANKRD1 mRNA CTD PMID:17211630 Ankrd1 Rat copper(II) sulfate increases expression ISO ANKRD1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ANKRD1 mRNA CTD PMID:19549813 Ankrd1 Rat cyclosporin A decreases expression ISO Ankrd1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 Ankrd1 Rat cyclosporin A decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ANKRD1 mRNA CTD PMID:27989131 Ankrd1 Rat cyclosporin A increases expression ISO ANKRD1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ANKRD1 mRNA CTD PMID:25562108 Ankrd1 Rat cylindrospermopsin increases expression ISO ANKRD1 (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of ANKRD1 mRNA CTD PMID:24921660 Ankrd1 Rat daunorubicin decreases expression EXP 6480464 Daunorubicin results in decreased expression of ANKRD1 mRNA CTD PMID:9278441 Ankrd1 Rat dexamethasone decreases expression ISO Ankrd1 (Mus musculus) 6480464 Dexamethasone results in decreased expression of ANKRD1 mRNA CTD PMID:22733784 Ankrd1 Rat dibutyl phthalate increases expression ISO Ankrd1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of ANKRD1 mRNA CTD PMID:21266533 Ankrd1 Rat dimethylarsinic acid multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 Ankrd1 Rat dimethylarsinous acid increases expression ISO ANKRD1 (Homo sapiens) 6480464 dimethylarsinous acid results in increased expression of ANKRD1 mRNA CTD PMID:23876855 Ankrd1 Rat dioxygen decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of ANKRD1 mRNA CTD PMID:24236059 Ankrd1 Rat dioxygen multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD1 mRNA CTD PMID:30529165 Ankrd1 Rat diquat increases expression ISO ANKRD1 (Homo sapiens) 6480464 Diquat results in increased expression of ANKRD1 mRNA CTD PMID:21172416 Ankrd1 Rat dorsomorphin multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ankrd1 Rat doxorubicin multiple interactions ISO Ankrd1 (Mus musculus) 6480464 CYP2J2 protein inhibits the reaction [Doxorubicin results in increased activity of ANKRD1 protein] CTD PMID:19429816 Ankrd1 Rat doxorubicin increases expression ISO ANKRD1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of ANKRD1 mRNA CTD PMID:29803840 Ankrd1 Rat doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of ANKRD1 protein CTD PMID:22532871 Ankrd1 Rat doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ANKRD1 mRNA and Doxorubicin results in decreased expression of ANKRD1 protein CTD PMID:22532871 and PMID:9278441 Ankrd1 Rat doxorubicin decreases expression ISO Ankrd1 (Mus musculus) 6480464 Doxorubicin results in decreased expression of ANKRD1 mRNA CTD PMID:17531194 Ankrd1 Rat doxorubicin increases expression ISO Ankrd1 (Mus musculus) 6480464 Doxorubicin results in increased expression of ANKRD1 mRNA and Doxorubicin results in increased expression of ANKRD1 protein CTD PMID:16243910 more ... Ankrd1 Rat Echimidine decreases expression EXP 6480464 echimidine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 Ankrd1 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ANKRD1 mRNA CTD PMID:29391264 Ankrd1 Rat esketamine decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Esketamine results in decreased expression of ANKRD1 mRNA CTD PMID:38219984 Ankrd1 Rat ethanol decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Ethanol results in decreased expression of ANKRD1 mRNA CTD PMID:31059573 and PMID:37149095 Ankrd1 Rat fenofibrate increases expression ISO Ankrd1 (Mus musculus) 6480464 Fenofibrate results in increased expression of ANKRD1 protein CTD PMID:39442682 Ankrd1 Rat fenofibrate multiple interactions ISO Ankrd1 (Mus musculus) 6480464 APOA2 protein alternative form affects the reaction [Fenofibrate results in increased expression of ANKRD1 protein] CTD PMID:39442682 Ankrd1 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ANKRD1 mRNA CTD PMID:30307764 Ankrd1 Rat folic acid increases expression ISO ANKRD1 (Homo sapiens) 6480464 Folic Acid results in increased expression of ANKRD1 mRNA CTD PMID:17868486 Ankrd1 Rat folic acid multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 Ankrd1 Rat formaldehyde decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of ANKRD1 mRNA CTD PMID:28937961 Ankrd1 Rat geldanamycin increases expression ISO ANKRD1 (Homo sapiens) 6480464 geldanamycin results in increased expression of ANKRD1 mRNA CTD PMID:26705709 Ankrd1 Rat gemcitabine increases expression ISO ANKRD1 (Homo sapiens) 6480464 Gemcitabine results in increased expression of ANKRD1 mRNA CTD PMID:17039268 Ankrd1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANKRD1 mRNA CTD PMID:33387578 Ankrd1 Rat Gingerenone A increases expression ISO ANKRD1 (Homo sapiens) 6480464 gingerenone A results in increased expression of ANKRD1 mRNA CTD PMID:35326237 Ankrd1 Rat Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 Ankrd1 Rat hydrogen peroxide affects expression ISO ANKRD1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ANKRD1 mRNA CTD PMID:20044591 Ankrd1 Rat iron dichloride increases expression ISO ANKRD1 (Homo sapiens) 6480464 ferrous chloride results in increased expression of ANKRD1 mRNA CTD PMID:35984750 Ankrd1 Rat L-methionine multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 Ankrd1 Rat leflunomide increases expression ISO ANKRD1 (Homo sapiens) 6480464 leflunomide results in increased expression of ANKRD1 mRNA CTD PMID:28988120 Ankrd1 Rat Licochalcone B increases expression ISO ANKRD1 (Homo sapiens) 6480464 licochalcone B results in increased expression of ANKRD1 mRNA CTD PMID:33647349 Ankrd1 Rat lipopolysaccharide multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ANKRD1 mRNA more ... CTD PMID:26667767 and PMID:35811015 Ankrd1 Rat lipopolysaccharide increases expression ISO ANKRD1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of ANKRD1 mRNA CTD PMID:35811015 Ankrd1 Rat manganese atom multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat manganese(0) multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat manganese(II) chloride multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat mercury dibromide increases expression ISO ANKRD1 (Homo sapiens) 6480464 mercuric bromide results in increased expression of ANKRD1 mRNA CTD PMID:26272509 Ankrd1 Rat mercury dibromide multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat methamphetamine decreases expression ISO Ankrd1 (Mus musculus) 6480464 Methamphetamine results in decreased expression of ANKRD1 mRNA CTD PMID:36914120 Ankrd1 Rat methylarsonic acid multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 Ankrd1 Rat methylisothiazolinone increases expression ISO ANKRD1 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ANKRD1 mRNA CTD PMID:31629900 Ankrd1 Rat methylmercury chloride decreases expression ISO ANKRD1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ANKRD1 mRNA CTD PMID:34089799 Ankrd1 Rat microcystin-LR increases expression ISO Ankrd1 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of ANKRD1 mRNA CTD PMID:37342990 Ankrd1 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of ANKRD1 mRNA CTD PMID:21515302 Ankrd1 Rat nickel sulfate decreases expression ISO ANKRD1 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of ANKRD1 mRNA CTD PMID:22714537 Ankrd1 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ANKRD1 mRNA CTD PMID:33484710 Ankrd1 Rat O-methyleugenol decreases expression ISO ANKRD1 (Homo sapiens) 6480464 methyleugenol results in decreased expression of ANKRD1 mRNA CTD PMID:32234424 Ankrd1 Rat p-chloromercuribenzoic acid increases expression ISO ANKRD1 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of ANKRD1 mRNA CTD PMID:26272509 Ankrd1 Rat p-chloromercuribenzoic acid multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat panobinostat multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat panobinostat increases expression ISO ANKRD1 (Homo sapiens) 6480464 panobinostat results in increased expression of ANKRD1 mRNA CTD PMID:26272509 Ankrd1 Rat paracetamol affects expression ISO Ankrd1 (Mus musculus) 6480464 Acetaminophen affects the expression of ANKRD1 mRNA CTD PMID:17562736 Ankrd1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ANKRD1 mRNA CTD PMID:33387578 Ankrd1 Rat paracetamol increases expression ISO ANKRD1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ANKRD1 mRNA CTD PMID:29067470 Ankrd1 Rat perfluorooctanoic acid decreases expression ISO ANKRD1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of ANKRD1 mRNA CTD PMID:32588087 Ankrd1 Rat phenobarbital affects expression ISO ANKRD1 (Homo sapiens) 6480464 Phenobarbital affects the expression of ANKRD1 mRNA CTD PMID:19159669 Ankrd1 Rat phenylmercury acetate increases expression ISO ANKRD1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of ANKRD1 mRNA CTD PMID:26272509 Ankrd1 Rat phenylmercury acetate multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat pirinixic acid multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANKRD1 mRNA CTD PMID:19710929 Ankrd1 Rat Platyphylline decreases expression EXP 6480464 platyphylline results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 Ankrd1 Rat propanal increases expression ISO ANKRD1 (Homo sapiens) 6480464 propionaldehyde results in increased expression of ANKRD1 mRNA CTD PMID:26079696 Ankrd1 Rat quinolin-8-ol increases expression ISO ANKRD1 (Homo sapiens) 6480464 Oxyquinoline results in increased expression of ANKRD1 mRNA CTD PMID:21632981 Ankrd1 Rat raloxifene multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ANKRD1 mRNA CTD PMID:19059307 Ankrd1 Rat resveratrol multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ANKRD1 mRNA CTD PMID:26667767 Ankrd1 Rat rotenone increases expression ISO Ankrd1 (Mus musculus) 6480464 Rotenone results in increased expression of ANKRD1 mRNA CTD PMID:32937126 Ankrd1 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ANKRD1 mRNA] CTD PMID:35811015 Ankrd1 Rat SB 431542 multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ankrd1 Rat senecionine decreases expression EXP 6480464 senecionine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 Ankrd1 Rat silicon dioxide increases expression ISO ANKRD1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of ANKRD1 mRNA CTD PMID:25895662 Ankrd1 Rat silver atom increases expression ISO ANKRD1 (Homo sapiens) 6480464 Silver results in increased expression of ANKRD1 mRNA CTD PMID:26014281 Ankrd1 Rat silver(0) increases expression ISO ANKRD1 (Homo sapiens) 6480464 Silver results in increased expression of ANKRD1 mRNA CTD PMID:26014281 Ankrd1 Rat sodium arsenate multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 Ankrd1 Rat sodium arsenite decreases expression ISO Ankrd1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of ANKRD1 mRNA CTD PMID:16014739 and PMID:37682722 Ankrd1 Rat sodium arsenite multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 Ankrd1 Rat sodium arsenite multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ANKRD1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANKRD1 mRNA CTD PMID:39836092 Ankrd1 Rat sodium arsenite increases expression ISO ANKRD1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ANKRD1 mRNA CTD PMID:29301061 and PMID:38568856 Ankrd1 Rat stigmasterol multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [NR1H4 gene mutant form affects the susceptibility to Stigmasterol] which results in decreased expression of ANKRD1 mRNA CTD PMID:30245210 Ankrd1 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ANKRD1 mRNA CTD PMID:16684804 Ankrd1 Rat streptozocin multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ANKRD1 mRNA] CTD PMID:16684804 Ankrd1 Rat sunitinib decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ANKRD1 mRNA CTD PMID:31533062 Ankrd1 Rat tacrolimus hydrate increases expression ISO Ankrd1 (Mus musculus) 6480464 Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 Ankrd1 Rat tamoxifen multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of ANKRD1 mRNA CTD PMID:19059307 Ankrd1 Rat temozolomide affects response to substance ISO ANKRD1 (Homo sapiens) 6480464 ANKRD1 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Ankrd1 Rat temozolomide increases expression ISO ANKRD1 (Homo sapiens) 6480464 Temozolomide results in increased expression of ANKRD1 mRNA CTD PMID:31758290 Ankrd1 Rat tetrachloromethane multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [calcipotriene co-treated with Verteporfin] promotes the reaction [Carbon Tetrachloride results in increased expression of ANKRD1 mRNA] more ... CTD PMID:38992766 Ankrd1 Rat tetrachloromethane increases expression ISO Ankrd1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ANKRD1 mRNA CTD PMID:38992766 Ankrd1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANKRD1 mRNA CTD PMID:34492290 Ankrd1 Rat thiram increases expression ISO ANKRD1 (Homo sapiens) 6480464 Thiram results in increased expression of ANKRD1 mRNA CTD PMID:38568856 Ankrd1 Rat titanium dioxide decreases expression ISO Ankrd1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of ANKRD1 mRNA CTD PMID:23557971 Ankrd1 Rat titanium dioxide increases expression ISO Ankrd1 (Mus musculus) 6480464 titanium dioxide results in increased expression of ANKRD1 mRNA CTD PMID:35295148 Ankrd1 Rat triadimefon decreases expression ISO ANKRD1 (Homo sapiens) 6480464 triadimefon results in decreased expression of ANKRD1 mRNA CTD PMID:26705709 Ankrd1 Rat trichloroethene decreases expression ISO Ankrd1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of ANKRD1 mRNA CTD PMID:25055964 Ankrd1 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ANKRD1 mRNA CTD PMID:33387578 Ankrd1 Rat trichostatin A increases expression ISO ANKRD1 (Homo sapiens) 6480464 trichostatin A results in increased expression of ANKRD1 mRNA CTD PMID:24935251 more ... Ankrd1 Rat trichostatin A multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat tris(2-butoxyethyl) phosphate affects expression ISO ANKRD1 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of ANKRD1 mRNA CTD PMID:29024780 Ankrd1 Rat troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ANKRD1 mRNA CTD PMID:21515302 Ankrd1 Rat tunicamycin increases expression ISO ANKRD1 (Homo sapiens) 6480464 Tunicamycin results in increased expression of ANKRD1 mRNA CTD PMID:29453283 Ankrd1 Rat urethane decreases expression ISO ANKRD1 (Homo sapiens) 6480464 Urethane results in decreased expression of ANKRD1 mRNA CTD PMID:28818685 Ankrd1 Rat valproic acid decreases expression ISO Ankrd1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of ANKRD1 mRNA CTD PMID:15799026 Ankrd1 Rat valproic acid multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 Ankrd1 Rat valproic acid increases expression ISO ANKRD1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ANKRD1 mRNA CTD PMID:23179753 more ... Ankrd1 Rat valproic acid affects expression ISO ANKRD1 (Homo sapiens) 6480464 Valproic Acid affects the expression of ANKRD1 mRNA CTD PMID:25979313 Ankrd1 Rat vanadyl sulfate multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ANKRD1 mRNA] CTD PMID:16684804 Ankrd1 Rat verteporfin multiple interactions ISO ANKRD1 (Homo sapiens) 6480464 verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA] CTD PMID:29725256 Ankrd1 Rat verteporfin multiple interactions ISO Ankrd1 (Mus musculus) 6480464 [calcipotriene co-treated with Verteporfin] promotes the reaction [Carbon Tetrachloride results in increased expression of ANKRD1 mRNA] more ... CTD PMID:29893953 and PMID:38992766 Ankrd1 Rat verteporfin decreases expression ISO ANKRD1 (Homo sapiens) 6480464 verteporfin results in decreased expression of ANKRD1 mRNA CTD PMID:29725256 Ankrd1 Rat vorinostat increases expression ISO ANKRD1 (Homo sapiens) 6480464 vorinostat results in increased expression of ANKRD1 mRNA CTD PMID:26272509
1,1-dichloroethene (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) amitriptyline (EXP) ammonium chloride (EXP) amphetamine (EXP) ampicillin (ISO) andrographolide (ISO) arsane (ISO) arsenic atom (ISO) atrazine (EXP) benzo[a]pyrene (ISO) beta-naphthoflavone (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) bleomycin A2 (ISO) Botulinum toxin type A (EXP) bromobenzene (EXP) butanal (ISO) cadmium atom (ISO) cadmium dichloride (ISO) cadmium sulfate (ISO) calcipotriol (ISO) cantharidin (ISO) carbon nanotube (ISO) carmustine (ISO) CGP 52608 (ISO) chlordecone (ISO) choline (ISO) cisplatin (EXP,ISO) cobalt dichloride (EXP,ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) cyclosporin A (ISO) cylindrospermopsin (ISO) daunorubicin (EXP) dexamethasone (ISO) dibutyl phthalate (ISO) dimethylarsinic acid (ISO) dimethylarsinous acid (ISO) dioxygen (ISO) diquat (ISO) dorsomorphin (ISO) doxorubicin (EXP,ISO) Echimidine (EXP) endosulfan (EXP) esketamine (ISO) ethanol (ISO) fenofibrate (ISO) fenvalerate (EXP) folic acid (ISO) formaldehyde (ISO) geldanamycin (ISO) gemcitabine (ISO) gentamycin (EXP) Gingerenone A (ISO) Heliotrine (EXP) hydrogen peroxide (ISO) iron dichloride (ISO) L-methionine (ISO) leflunomide (ISO) Licochalcone B (ISO) lipopolysaccharide (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) mercury dibromide (ISO) methamphetamine (ISO) methylarsonic acid (ISO) methylisothiazolinone (ISO) methylmercury chloride (ISO) microcystin-LR (ISO) Muraglitazar (EXP) nickel sulfate (ISO) nitrofen (EXP) O-methyleugenol (ISO) p-chloromercuribenzoic acid (ISO) panobinostat (ISO) paracetamol (EXP,ISO) perfluorooctanoic acid (ISO) phenobarbital (ISO) phenylmercury acetate (ISO) pirinixic acid (ISO) Platyphylline (EXP) propanal (ISO) quinolin-8-ol (ISO) raloxifene (ISO) resveratrol (ISO) rotenone (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) senecionine (EXP) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenate (ISO) sodium arsenite (ISO) stigmasterol (ISO) streptozocin (EXP) sunitinib (ISO) tacrolimus hydrate (ISO) tamoxifen (ISO) temozolomide (ISO) tetrachloromethane (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) triadimefon (ISO) trichloroethene (EXP,ISO) trichostatin A (ISO) tris(2-butoxyethyl) phosphate (ISO) troglitazone (EXP) tunicamycin (ISO) urethane (ISO) valproic acid (ISO) vanadyl sulfate (EXP) verteporfin (ISO) vorinostat (ISO)
Biological Process
cardiac muscle tissue morphogenesis (IEA,ISO) cellular response to hypoxia (IEP) cellular response to interleukin-1 (IEA,ISO) cellular response to lipopolysaccharide (IEA,ISO) cellular response to mechanical stimulus (IEA,ISO) cellular response to transforming growth factor beta stimulus (IEA,ISO) cellular response to tumor necrosis factor (IEA,ISO) cellular response to xenobiotic stimulus (ISO) negative regulation of DNA biosynthetic process (IEA,ISO) negative regulation of DNA-templated transcription (TAS) negative regulation of transcription by RNA polymerase II (IDA) phospholipase C/protein kinase C signal transduction (ISO) positive regulation of apoptotic process (IEA,ISO) positive regulation of DNA damage response, signal transduction by p53 class mediator (IEA,ISO) positive regulation of DNA-templated transcription (IEA) positive regulation of neuron projection development (IMP) positive regulation of protein secretion (IEA,ISO) regulation of transcription by RNA polymerase II (IBA,ISO) response to muscle stretch (IEA,ISO) skeletal muscle cell differentiation (ISO)
1.
Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.
Aihara Y, etal., Hypertension. 2000 Jul;36(1):48-53.
2.
Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways.
Aihara Y, etal., J Mol Cell Cardiol. 2000 Aug;32(8):1401-14.
3.
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
Arimura T, etal., J Am Coll Cardiol. 2009 Jul 21;54(4):334-42.
4.
Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.
Bang ML, etal., J Cell Biol. 2001 Apr 16;153(2):413-27.
5.
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
Duboscq-Bidot L, etal., Eur Heart J. 2009 Sep;30(17):2128-36. Epub 2009 Jun 12.
6.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
7.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
8.
Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells.
Han XJ, etal., J Biol Chem. 2005 Jun 17;280(24):23122-9. Epub 2005 Apr 12.
9.
Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury.
Lee MJ, etal., Exp Mol Med. 2009 Apr 30;41(4):243-52.
10.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
11.
Carotid surgery.
Munro E, Eur J Vasc Endovasc Surg. 1998 Aug;16(2):170-1.
12.
Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy.
Nakada C, etal., Pathol Int. 2003 Oct;53(10):653-8.
13.
GOA pipeline
RGD automated data pipeline
14.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
15.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
16.
CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue.
Shi Y, etal., Am J Pathol. 2005 Jan;166(1):303-12.
17.
Identification of candidate transcriptional modulators involved in successful regeneration after nerve injury.
Stam FJ, etal., Eur J Neurosci. 2007 Jun;25(12):3629-37.
18.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
19.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
20.
Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C.
Uys GM, etal., BMC Cell Biol. 2011 May 10;12:18. doi: 10.1186/1471-2121-12-18.
21.
CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway.
Zou Y, etal., Development. 1997 Feb;124(4):793-804.
Ankrd1 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 243,228,460 - 243,237,014 (-) NCBI GRCr8 mRatBN7.2 1 233,815,851 - 233,834,891 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 233,815,851 - 233,834,919 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 242,212,709 - 242,221,290 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 249,129,677 - 249,138,264 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 241,967,834 - 241,976,421 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 254,726,985 - 254,745,673 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 254,726,969 - 254,735,548 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 262,038,137 - 262,046,691 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 240,316,123 - 240,324,804 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 240,490,005 - 240,498,684 (-) NCBI Celera 1 230,914,960 - 230,923,398 (-) NCBI Celera Cytogenetic Map 1 q53 NCBI
ANKRD1 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 90,912,096 - 90,921,087 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 90,912,096 - 90,921,087 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 10 92,671,853 - 92,680,844 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 92,661,837 - 92,671,012 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 10 92,661,836 - 92,671,012 NCBI Celera 10 86,418,314 - 86,427,472 (-) NCBI Celera Cytogenetic Map 10 q23.31 NCBI HuRef 10 86,300,878 - 86,309,941 (-) NCBI HuRef CHM1_1 10 92,949,704 - 92,958,879 (-) NCBI CHM1_1 T2T-CHM13v2.0 10 91,795,773 - 91,804,766 (-) NCBI T2T-CHM13v2.0
Ankrd1 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 19 36,089,365 - 36,097,244 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 19 36,089,361 - 36,097,499 (-) Ensembl GRCm39 Ensembl GRCm38 19 36,111,965 - 36,119,844 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 19 36,111,961 - 36,120,099 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 19 36,186,455 - 36,194,334 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 19 36,177,109 - 36,184,988 (-) NCBI MGSCv36 mm8 Celera 19 36,887,384 - 36,895,221 (-) NCBI Celera Cytogenetic Map 19 C2 NCBI cM Map 19 30.52 NCBI
Ankrd1 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955425 2,258,392 - 2,267,878 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955425 2,258,554 - 2,267,699 (+) NCBI ChiLan1.0 ChiLan1.0
ANKRD1 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 8 102,942,181 - 102,951,190 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 10 102,948,133 - 102,956,491 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 10 87,652,254 - 87,661,173 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 10 91,179,325 - 91,188,414 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 10 91,180,034 - 91,188,165 (-) Ensembl panpan1.1 panPan2
ANKRD1 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 28 5,569,120 - 5,578,393 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 28 5,569,501 - 5,601,956 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 28 5,736,579 - 5,745,849 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 28 5,789,401 - 5,799,972 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 28 5,789,403 - 5,823,534 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 28 5,546,460 - 5,555,716 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 28 5,585,466 - 5,594,725 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 28 5,750,959 - 5,760,237 (-) NCBI UU_Cfam_GSD_1.0
Ankrd1 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 41,870,291 - 41,878,306 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936601 3,502,844 - 3,511,003 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936601 3,502,844 - 3,510,919 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ANKRD1 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 102,603,777 - 102,612,839 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 102,603,777 - 102,612,857 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 111,714,967 - 111,724,055 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ANKRD1 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 9 84,248,133 - 84,257,276 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 9 84,247,241 - 84,257,170 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 44,957,846 - 44,966,995 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ankrd1
.
Assembly: Rnor_6.0
Chromosome Start Pos End Pos Reference Nucleotide Variant Nucleotide Variant Type Strain Variant Page
1
254735067
254735068
T
A
snv
GK/Ox (RGD) , SHR/NHsd (RGD), BXH2/CubMcwi (2020), GK/FarMcwi (2019), HXB20/IpcvMcwi (2020), European Variation Archive Release 6, HXB4/IpcvMcwi (2020), SHR/OlalpcvMcwi (2019), European Variation Archive Release 3, European Variation Archive Release 4, HXB2/IpcvMcwi (2019) View more Information
Predicted Target Of
Count of predictions: 104 Count of miRNA genes: 85 Interacting mature miRNAs: 99 Transcripts: ENSRNOT00000025258 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
8693637 Alc29 Alcohol consumption QTL 29 2.7 0.258 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 1 207987464 234238494 Rat 1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 1357335 Bw39 Body weight QTL 39 3.3 body mass (VT:0001259) body weight (CMO:0000012) 1 197814409 242814409 Rat 2302375 Bw83 Body weight QTL 83 4.87 0.0002 body mass (VT:0001259) body weight (CMO:0000012) 1 197697768 242697768 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2293674 Bss39 Bone structure and strength QTL 39 7.1 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 1 201554356 246554356 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 61455 Niddm7 Non-insulin dependent diabetes mellitus QTL 7 5.5 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 214537555 238757011 Rat 61327 Eae7 Experimental allergic encephalomyelitis QTL 7 5.6 body mass (VT:0001259) change in body weight (CMO:0002045) 1 216255568 260522016 Rat 1600392 Bw123 Body weight QTL 123 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 223201027 260522016 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 2.2 uterus morphology trait (VT:0001120) percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759) 1 206081677 251081677 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 2293694 Bss38 Bone structure and strength QTL 38 7.05 0.0001 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 1 201554356 246554356 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 1300108 Rf8 Renal function QTL 8 3.75 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 1 228581588 259647894 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 body mass (VT:0001259) body weight (CMO:0000012) 1 224054293 260122809 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631215 Stl8 Serum triglyceride level QTL 8 9.27 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 1 225126575 260522016 Rat 631843 Bw116 Body weight QTL 116 4.1 0.016 abdominal adipose amount (VT:1000220) abdominal fat pad weight (CMO:0000088) 1 224054293 260122809 Rat 2300175 Bmd40 Bone mineral density QTL 40 15.4 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 1 201554356 246554356 Rat 731175 Uae20 Urinary albumin excretion QTL 20 3.5 0.0018 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 221264111 259647894 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 724538 Kidm1 Kidney mass QTL 1 3.2 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 213707201 252085212 Rat 2293655 Bss36 Bone structure and strength QTL 36 10.66 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 201554356 246554356 Rat 1298084 Thym4 Thymus enlargement QTL 4 10.68 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 197814409 242814409 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 8552891 Epfw5 Epididymal fat weight QTL 5 4.4 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 1 193113876 238113876 Rat 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 body mass (VT:0001259) body weight (CMO:0000012) 1 224569538 260122809 Rat 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 body mass (VT:0001259) body weight (CMO:0000012) 1 213843987 258843987 Rat 1358890 Bp259 Blood pressure QTL 259 3.06 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 210702053 260522016 Rat 724533 Rf51 Renal function QTL 51 5.3 0.0002 kidney plasma flow trait (VT:0005524) renal plasma flow (CMO:0001914) 1 218753816 256448513 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 1358292 Cm37 Cardiac mass QTL 37 6.2 8e-07 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 1 196248093 241248093 Rat 61376 Bp42 Blood pressure QTL 42 23.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 197814409 242814409 Rat 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 199050459 259647894 Rat 1549910 Bw54 Body weight QTL 54 0.05 body mass (VT:0001259) body weight (CMO:0000012) 1 214647894 259647894 Rat 70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 3.79 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 214647894 259647894 Rat 1357399 Bw45 Body weight QTL 45 3.05 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 1 206329708 251329708 Rat 724552 Glom2 Glomerulus QTL 2 3.3 0.0001 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) 1 222363780 260522016 Rat 2316896 Gluco57 Glucose level QTL 57 7.2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 228985440 245907899 Rat 1357404 Bw42 Body weight QTL 42 4.49 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 206329708 251329708 Rat 10053715 Scort24 Serum corticosterone level QTL 24 2.13 0.0088 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 221414816 260522016 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 1358916 Kidm22 Kidney mass QTL 22 3.32 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 210702053 240947965 Rat 634321 Hc1 Hypercalciuria QTL 1 2.91 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 178810256 240830002 Rat 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 11 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 218753689 245907899 Rat 10059587 Bw173 Body weight QTL 173 3.23 0.025 body mass (VT:0001259) body weight (CMO:0000012) 1 202069611 247069611 Rat 2292216 Bw80 Body weight QTL 80 3.23 0.0019 body mass (VT:0001259) body weight (CMO:0000012) 1 213533809 243914901 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 10059590 Kidm44 Kidney mass QTL 44 3.42 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 191033875 236033875 Rat 1641926 Teswt2 Testicular weight QTL 2 2.82 testis mass (VT:1000644) both testes wet weight (CMO:0000175) 1 197697768 238755659 Rat 631658 Cm7 Cardiac mass QTL 7 5.32 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 1 196248093 241248093 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 2293700 Bmd27 Bone mineral density QTL 27 6.6 0.0001 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 1 224054293 243747962 Rat 2293701 Bmd34 Bone mineral density QTL 34 8.3 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 1 224054293 243747962 Rat 7387289 Uae45 Urinary albumin excretion QTL 45 2.86 0.0021 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 223262787 260522016 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 3 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 197670404 242670404 Rat 1581544 Rf52 Renal function QTL 52 0.05 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 1 232156370 259647894 Rat 1600363 Hc6 Hypercalciuria QTL 6 2.7 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 203995416 244113296 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 2302040 Pia35 Pristane induced arthritis QTL 35 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 216255568 260522016 Rat 631669 Iddm9 Insulin dependent diabetes mellitus QTL 9 2.8 0.039 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 233190394 258625266 Rat 7394701 Uae46 Urinary albumin excretion QTL 46 3.6 0.0056 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 201554356 246554356 Rat 1598821 Rf55 Renal function QTL 55 6.3 renal blood flow trait (VT:2000006) ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239) 1 218748008 257976495 Rat
RH128736
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,815,953 - 233,816,154 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,727,088 - 254,727,288 NCBI Rnor6.0 Rnor_5.0 1 262,046,397 - 262,046,597 UniSTS Rnor5.0 RGSC_v3.4 1 240,316,217 - 240,316,417 UniSTS RGSC3.4 Celera 1 230,915,054 - 230,915,254 UniSTS RH 3.4 Map 1 1586.6 UniSTS Cytogenetic Map 1 q53 UniSTS
RH130311
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,815,948 - 233,816,148 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,727,083 - 254,727,282 NCBI Rnor6.0 Rnor_5.0 1 262,046,403 - 262,046,602 UniSTS Rnor5.0 RGSC_v3.4 1 240,316,212 - 240,316,411 UniSTS RGSC3.4 Celera 1 230,915,049 - 230,915,248 UniSTS RH 3.4 Map 4 511.12 UniSTS Cytogenetic Map 1 q53 UniSTS
RH134094
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,825,496 - 233,825,716 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,736,633 - 254,736,852 NCBI Rnor6.0 Rnor_5.0 1 262,036,833 - 262,037,052 UniSTS Rnor5.0 RGSC_v3.4 1 240,325,889 - 240,326,108 UniSTS RGSC3.4 Celera 1 230,924,483 - 230,924,702 UniSTS RH 3.4 Map 1 1584.7 UniSTS Cytogenetic Map 1 q53 UniSTS
AI556107
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,816,132 - 233,816,269 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,727,267 - 254,727,403 NCBI Rnor6.0 Rnor_5.0 1 262,046,282 - 262,046,418 UniSTS Rnor5.0 RGSC_v3.4 1 240,316,396 - 240,316,532 UniSTS RGSC3.4 Celera 1 230,915,233 - 230,915,369 UniSTS RH 3.4 Map 1 1586.91 UniSTS Cytogenetic Map 1 q53 UniSTS
RH140168
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,820,715 - 233,820,928 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,731,853 - 254,732,065 NCBI Rnor6.0 Rnor_5.0 1 262,041,620 - 262,041,832 UniSTS Rnor5.0 RGSC_v3.4 1 240,321,109 - 240,321,321 UniSTS RGSC3.4 Celera 1 230,919,703 - 230,919,915 UniSTS Cytogenetic Map 1 q53 UniSTS
Ankrd1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 233,820,013 - 233,821,266 (+) MAPPER mRatBN7.2 Rnor_6.0 1 254,731,151 - 254,732,403 NCBI Rnor6.0 Rnor_5.0 1 262,041,282 - 262,042,534 UniSTS Rnor5.0 Celera 1 230,919,001 - 230,920,253 UniSTS Cytogenetic Map 1 q53 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000025258 ⟹ ENSRNOP00000025258
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,853 - 233,824,410 (-) Ensembl Rnor_6.0 Ensembl 1 254,726,969 - 254,735,548 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000097402 ⟹ ENSRNOP00000084263
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,854 - 233,824,597 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000108356 ⟹ ENSRNOP00000083877
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,851 - 233,824,403 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000108831 ⟹ ENSRNOP00000088225
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,851 - 233,824,403 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000117221 ⟹ ENSRNOP00000097020
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,853 - 233,834,919 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000120144 ⟹ ENSRNOP00000097010
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 233,815,857 - 233,824,289 (-) Ensembl
RefSeq Acc Id:
NM_013220 ⟹ NP_037352
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 243,228,460 - 243,237,014 (-) NCBI mRatBN7.2 1 233,815,860 - 233,824,412 (-) NCBI Rnor_6.0 1 254,726,994 - 254,735,548 (-) NCBI Rnor_5.0 1 262,038,137 - 262,046,691 (+) NCBI RGSC_v3.4 1 240,316,123 - 240,324,804 (-) RGD Celera 1 230,914,960 - 230,923,398 (-) RGD
Sequence:
CCCGGGCAGGTCCAGGGGTTCAGCCACAAGAGGGAAAAACATAGACTAACGGCTGCCAACATGATGGTTTTTCGAGTAGAGGAGCTGGTAACGGGCAAAAAGAACAGCAATGGGTCCTCAGGGGAGTT
hide sequence
RefSeq Acc Id:
NP_037352 ⟸ NM_013220
- UniProtKB:
Q8R560 (UniProtKB/Swiss-Prot), Q9Z1F0 (UniProtKB/Swiss-Prot), A6I150 (UniProtKB/TrEMBL), A0A8I6GLV4 (UniProtKB/TrEMBL)
- Sequence:
MMVFRVEELVTGKKNSNGSSGEFLPGEFRNGEYEAAVALEKQEDLKTLPANSVNLGEEQRKSEKVREAELKKKKLEQRSKLENLEDLEIIVQLKKRKKYKKTKVPVVKEPEPEIITEPVDVPRFLKAA
hide sequence
Ensembl Acc Id:
ENSRNOP00000025258 ⟸ ENSRNOT00000025258
Ensembl Acc Id:
ENSRNOP00000097010 ⟸ ENSRNOT00000120144
Ensembl Acc Id:
ENSRNOP00000088225 ⟸ ENSRNOT00000108831
Ensembl Acc Id:
ENSRNOP00000097020 ⟸ ENSRNOT00000117221
Ensembl Acc Id:
ENSRNOP00000083877 ⟸ ENSRNOT00000108356
Ensembl Acc Id:
ENSRNOP00000084263 ⟸ ENSRNOT00000097402
RGD ID: 13690871 Promoter ID: EPDNEW_R1396 Type: single initiation site Name: Ankrd1_1 Description: ankyrin repeat domain 1 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 254,735,550 - 254,735,610 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Ankrd1
ankyrin repeat domain 1
LOC102552909
uncharacterized LOC102552909
Data merged from RGD:7602717
737654 PROVISIONAL
2013-12-18
LOC102552909
uncharacterized LOC102552909
Symbol and Name status set to provisional
70820 PROVISIONAL
2004-02-05
Ankrd1
ankyrin repeat domain 1 (cardiac muscle)
Alrp
ankyrin-like repeat protein
Symbol and name updated to reflect Human and Mouse nomenclature
625702 APPROVED
2002-06-10
Alrp
ankyrin-like repeat protein
Name updated
70584 APPROVED
Note Type
Note
Reference
gene_cellular_localization
localized to the nucleus
634545
gene_drugs
expression is inhibited by the antineoplastic drug doxorubicin
634545
gene_expression
expressed in cardiomyocytes
634545
